Notification about latest news from us.
A study clarifies the role of BRCA2 mutations, helping to target cancer treatment and reassure patients about their risks.
Despite the rise in prenatal genetic screening, it cannot identify all genetic conditions, especially mitochondrial and epigenetic disorders.
By clicking send you'll receive occasional emails from newsletters about this topic.